Patents Assigned to Jounce Therapeutics, Inc.
  • Compositions and Methods for the Treatment of Cancer
    Publication number: 20200024351
    Abstract: Methods of treating cancer with particular doses of anti-ICOS antibodies are provided.
    Type: Application
    Filed: April 2, 2018
    Publication date: January 23, 2020
    Applicant: Jounce Therapeutics, Inc.
    Inventors: Jason Windham Reeves, Deborah Law, Christopher Harvey, Beth G. Trehu, Lauren Pepper MacKenzie, Amit Deshpande, Jennifer S. Michaelson, Igor Feldman, Sriram Sathyanarayanan
  • GENE SIGNATURES FOR DETERMINING ICOS EXPRESSION
    Publication number: 20180371091
    Abstract: Gene expression signatures correlating to ICOS expression levels are provided. Methods of treatment comprising determining ICOS expression levels using gene signatures in patients and administering anti-ICOS antibodies are also provided.
    Type: Application
    Filed: October 21, 2016
    Publication date: December 27, 2018
    Applicant: Jounce Therapeutics, Inc.
    Inventors: Jason Windham Reeves, Igor Feldman, Christopher Harvey, Sriram Sathyanarayanan, Heather Hirsch, Lauren Pepper MacKenzie, Amit Deshpande, Stephen Sazinsky, Jennifer S. Michaelson, Kutlu Gosku Elpek
  • Antibodies to ICOS
    Publication number: 20180355041
    Abstract: Provided herein are various embodiments relating to antibodies. Some of the embodiments include agonist antibodies that bind ICOS. Such antibodies can be used in methods to treat, for example, cancer.
    Type: Application
    Filed: June 20, 2018
    Publication date: December 13, 2018
    Applicant: Jounce Therapeutics, Inc.
    Inventors: Stephen Sazinsky, Jennifer S. Michaelson, Sriram Sathyanarayanan, Kutlu Goksu Elpek
  • Antibodies to ICOS
    Patent number: 10023635
    Abstract: Provided herein are various embodiments relating to antibodies. Some of the embodiments include agonist antibodies that bind ICOS. Such antibodies can be used in methods to treat, for example, cancer.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: July 17, 2018
    Assignee: Jounce Therapeutics, Inc.
    Inventors: Stephen Sazinsky, Jennifer S. Michaelson, Sriram Sathyanarayanan, Kutlu Goksu Elpek
  • ANTIBODIES TO PD-1 AND USES THEREOF
    Publication number: 20180118829
    Abstract: Provided herein are various embodiments relating to antibodies. Some of the embodiments include antagonist antibodies that bind PD-1. Such antibodies can be used in methods to treat, for example, cancer.
    Type: Application
    Filed: November 1, 2017
    Publication date: May 3, 2018
    Applicant: Jounce Therapeutics, Inc.
    Inventors: George Robert Mabry, III, Stephen Sazinsky